Medullary thyroid carcinoma – Adverse events during systemic treatment: risk-benefit ratio

Medullary thyroid carcinoma (MTC) is a rare neuroendocrine tumor originating from parafollicular C cells of the thyroid and associated with mutations in the proto-oncogene REarranged during Transfection (RET). The prognosis of MTC depends on clinical stage, with a 95.6% 10-year survival rate among p...

Descripción completa

Detalles Bibliográficos
Autores principales: Maciel, Léa Maria Zanini, Magalhães, Patrícia Künzle Ribeiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Endocrinologia e Metabologia 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10118930/
https://www.ncbi.nlm.nih.gov/pubmed/28658345
http://dx.doi.org/10.1590/2359-3997000000267

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10118930/
https://www.ncbi.nlm.nih.gov/pubmed/28658345
http://dx.doi.org/10.1590/2359-3997000000267

Ejemplares similares